1. "Myeloma"
  2. "Xiuyan Wang"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (5)
Groups
  1. Adult Leukemia (10)
  2. Center for Hematologic Malignancies (10)
  3. Department of Medicine (10)
  4. Hematologic Malignancies Research (10)
  5. Hematologic Malignancies, Division of (10)
  6. Myeloma (10)

More Groups

People
  1. Isabelle Riviere (10)
  2. Xiuyan Wang (10)
  3. Renier Brentjens (9)
  4. Eric Smith (8)
  5. Terence Purdon (7)
  6. Brigitte Senechal (6)

More People

Years
  1. 2022 (2)
  2. 2021 (2)
  3. 2019 (2)
  4. 2018 (3)
  5. 2017 (1)
Publications
  1. Blood (4)
  2. Cancer Immunology Research (1)
  3. Clinical Lymphoma, Myeloma and Leukemia (1)
  4. Molecular Therapy (1)
  5. Molecular Therapy - Methods & Clinical Development (1)
  6. New England Journal of Medicine (1)

More Publications

Publishers
  1. American Society of Hematology (4)
  2. Nature Publishing Group (2)
  3. American Association for Cancer Research (1)
  4. American Association for the Advancement of Science (1)
  5. Elsevier Inc. (1)
  6. Massachusetts Medical Society (1)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: Initial experience in two clinical trials
    Meeting Abstract

    Qualls, D.; Monette, S.; Sethi, S.; Dogan, A.; Roshal, M.; Senechal, B.; Wang, X.; Riviere, I.; Sadelain, M.; Brentjens, R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • GPRC5D-targeted CAR T cells for myeloma
    Journal Article

    Mailankody, S.; Devlin, S. M.; Landa, J.; Nath, K.; Diamonte, C.; Carstens, E. J.; Russo, D.; Auclair, R.; Fitzgerald, L.; Cadzin, B.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Phase I first-in-class trial of MCARH109, a G protein coupled receptor class C group 5 member D (GPRC5D) targeted CAR T cell therapy in patients with relapsed or refractory multiple myeloma
    Meeting Abstract

    Mailankody, S.; Diamonte, C.; Fitzgerald, L.; Kane, P.; Wang, X.; Sikder, D. S.; Senechal, B.; Bermudez, V. P.; Frias, D.; Morgan, J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Depletion of high-content CD14(+) cells from apheresis products is critical for successful transduction and expansion of CAR T cells during large-scale cGMP manufacturing
    Journal Article

    Wang, X.; Borquez-Ojeda, O.; Stefanski, J.; Du, F.; Qu, J.; Chaudhari, J.; Thummar, K.; Zhu, M.; Shen, L. B.; Hall, M.; more...
    Molecular Therapy - Methods & Clinical Development (2021)

    Fulltext@MSK | Save
  • BCMA-targeted CAR T-cell therapy plus radiotherapy for the treatment of refractory myeloma reveals potential synergy
    Journal Article

    Smith, E. L.; Mailankody, S.; Staehr, M.; Wang, X.; Senechal, B.; Purdon, T. J.; Daniyan, A. F.; Geyer, M. B.; Goldberg, A. D.; Mead, E.; more...
    Cancer Immunology Research (2019)

    Fulltext@MSK | Save
  • GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells
    Journal Article

    Smith, E. L.; Harrington, K.; Staehr, M.; Masakayan, R.; Jones, J.; Long, T. J.; Ng, K. Y.; Ghoddusi, M.; Purdon, T. J.; Wang, X.; more...
    Science Translational Medicine (2019)

    Fulltext@MSK | Save
  • CAR T cell therapy targeting G protein-coupled receptor class C group 5 member D (GPRC5D), a novel target for the immunotherapy of multiple myeloma
    Meeting Abstract

    Smith, E. L.; Harrington, K.; Staehr, M.; Masakayan, R.; Jones, J.; Long, T.; Ghoddusi, M.; Purdon, T. J.; Do, T.; Wang, X.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial
    Meeting Abstract

    Mailankody, S.; Ghosh, A.; Staehr, M.; Purdon, T. J.; Roshal, M.; Halton, E.; Diamonte, C.; Pineda, J.; Anant, P.; Bernal, Y.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Development and evaluation of an optimal human single-chain variable fragment-derived BCMA-targeted CAR T cell vector
    Journal Article

    Smith, E. L.; Staehr, M.; Masakayan, R.; Tatake, I. J.; Purdon, T. J.; Wang, X.; Wang, P.; Liu, H.; Xu, Y.; Garrett-Thomson, S. C.; more...
    Molecular Therapy (2018)

    Fulltext@MSK | Save
  • Development and evaluation of a human single chain variable fragment (scFv) derived BCMA targeted CAR T Cell vector leads to a high objective response rate in patients with advanced MM
    Meeting Abstract

    Smith, E. L.; Mailankody, S.; Ghosh, A.; Masakayan, R.; Staehr, M.; Purdon, T. J.; Halton, E.; Diamonte, C.; Anant, P.; Bernal, Y.; more...
    Blood (2017)

    Fulltext@MSK | Save